Teva Pharmaceuticals has joined other drug makers in filing a lawsuit against the Department of Health and Human Services for the drug-pricing provisions of the Inflation Reduction Act.

Teva filed the civil action on Wednesday in federal court in Washington, D.C. as the Centers for Medicare and Medicaid Services released the next 15 drugs subject to price negotiations.